Literature DB >> 12499878

Characterization of fibroblasts from rejecting tissue: the hyaluronan production is increased.

Josefin Hellkvist1, Gunnar Tufveson, Bengt Gerdin, Cecilia Johnsson.   

Abstract

BACKGROUND: Interstitial edema of rejecting tissue can be partly attributed to the local accumulation of hyaluronan, which has strong water-binding capacity. The aim of the present study was to isolate fibroblasts from rejecting tissue and compare them, in terms of hyaluronan production and proliferation rate, with fibroblasts obtained from nontransplanted tissue. Furthermore, the fibroblast response to various cytokines involved in the rejection process was studied.
METHODS: Fibroblasts were isolated from normal rat heart tissue and from cardiac allografts undergoing rejection. The various preparations were characterized with regard to hyaluronan production (radiometric assay) and cell proliferation ( H-thymidine incorporation). In addition, the effects of tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, and interleukin (IL)-2 on these parameters were studied.
RESULTS: Fibroblasts isolated from rejecting hearts displayed strongly up-regulated hyaluronan production and proliferation rate as compared with fibroblasts obtained from normal tissue. In the presence of TNF-alpha, the proliferation of nonconfluent cells was augmented, whereas in confluent cultures of fibroblasts from rejecting tissue, the proliferation was inhibited. IFN-gamma stimulated both hyaluronan secretion and proliferation in confluent fibroblasts from rejecting hearts but had no effect on fibroblasts from normal tissue. IL-2, finally, reduced the hyaluronan production of nonconfluent cells.
CONCLUSIONS: The activation of fibroblasts is increased in rejecting tissue. As a result, the hyaluronan concentration is elevated which, in vivo, contributes to the formation of an interstitial edema and a subsequently increased tissue pressure. Several cytokines present at rejection are involved also in the regulation of fibroblast activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499878     DOI: 10.1097/00007890-200212270-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

Review 1.  Graft rejection - endogenous or allogeneic?

Authors:  William R Critchley; James E Fildes
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 2.  Could interferon-gamma be a therapeutic target for treating heart failure?

Authors:  Scott P Levick; Paul H Goldspink
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

3.  Effects of commonly used immunosuppressants on graft-derived fibroblasts.

Authors:  C Johnsson; B Gerdin; G Tufveson
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 4.  Sterile inflammation in thoracic transplantation.

Authors:  C Corbin Frye; Amit I Bery; Daniel Kreisel; Hrishikesh S Kulkarni
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.